Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. (Q45957677)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 June 2009

Language	Label	Description	Also known as
English	Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial.	scientific article published on 23 June 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

reproducibility

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Matthew D Blackledge

object named as

Matthew Blackledge

2

0 references

object named as

Dow-Mu Koh

1

0 references

Anwar R Padhani

4

object named as

Anwar R Padhani

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

author name string

David J Collins

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Toni Wallace

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Benjamin Wilton

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

N Jane Taylor

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

J James Stirling

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Rajesh Sinha

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Pat Walicke

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Ian Judson

12

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Paul Nathan

13

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

language of work or name

0 references

publication date

23 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

European Radiology

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

19

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

2728-2738

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-weighted MRI in the body: applications and challenges in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring agreement in method comparison studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic therapy for cancer: current and emerging concepts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion MRI for prediction of response of rectal cancer to chemoradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developing a quality control protocol for diffusion imaging on a clinical MRI system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-009-1469-4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19547986

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45957677&oldid=2207487171"